Tower Research Capital LLC (TRC) - ACURX PHARMACEUTICALS INC ownership

ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 13 filers reported holding ACURX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACURX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,646
-9.6%
7,097
+59.7%
0.00%
Q2 2023$11,779
+117690.0%
4,445
+53.8%
0.00%
Q1 2023$10
-16.7%
2,890
-0.2%
0.00%
Q4 2022$12
-99.9%
2,895
-0.2%
0.00%
Q3 2022$9,000
+28.6%
2,902
+65.4%
0.00%
Q2 2022$7,000
-36.4%
1,755
-47.1%
0.00%
Q1 2022$11,000
+175.0%
3,319
+369.4%
0.00%
Q3 2021$4,000
+33.3%
707
+53.0%
0.00%
Q2 2021$3,0004620.00%
Other shareholders
ACURX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Draper Asset Management, LLC 266,025$1,058,7801.47%
ARMISTICE CAPITAL, LLC 880,000$3,502,4000.06%
Semmax Financial Advisors Inc. 5,879$240.01%
Belpointe Asset Management LLC 3,000$11,9400.00%
TD Waterhouse Canada Inc. 18,656$77,4220.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 10,100$40,1980.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 77,283$3070.00%
MILLENNIUM MANAGEMENT LLC 29,096$1160.00%
BlackRock Inc. 15,639$62,2430.00%
View complete list of ACURX PHARMACEUTICALS INC shareholders